Ignite Creation Date:
2024-05-06 @ 2:11 PM
Last Modification Date:
2024-10-26 @ 1:26 PM
Study NCT ID:
NCT04240106
Status:
COMPLETED
Last Update Posted:
2024-02-16
First Post:
2020-01-14
Brief Title:
Niraparib Plus Aromatase Inhibitors for Luminal-likeHER2-ER and gBRCA or HDR Metastatic Breast Cancer LUZERN
Sponsor:
MedSIR
Organization:
MedSIR
Organization Data
Organization:
MedSIR
Class:
OTHER
Study ID:
MedOPP190
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedSIR
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |